Chapter 42. Follicular Lymphoma

  1. Mark A. Crowther MD, MSc, FRCPC Professor Division Director4,5,
  2. Jeff Ginsberg MD, FRCPC Professor6,
  3. Holger J. Schünemann MD, PhD, MSc, FACP, FCCP Professor7,8,
  4. Ralph M. Meyer MD, FRCPC Director Professor9,10 and
  5. Richard Lottenberg MD, FACP Professor11
  1. Kevin Imrie MD, FRCPC Chair1,2 and
  2. Matthew Cheung MD SM FRCP(C)3

Published Online: 4 FEB 2009

DOI: 10.1002/9781444300857.ch42

Evidence-Based Hematology

Evidence-Based Hematology

How to Cite

Imrie, K. and Cheung, M. (2008) Follicular Lymphoma, in Evidence-Based Hematology (eds M. A. Crowther, J. Ginsberg, H. J. Schünemann, R. M. Meyer and R. Lottenberg), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444300857.ch42

Editor Information

  1. 4

    Division of Hematology, McMaster University, Hamilton, Ontario, Canada

  2. 5

    St. Joseph's Hospital, Hamilton, Ontario, Canada

  3. 6

    Department of Medicine, McMaster University, Hamilton, Canada

  4. 7

    CLARITY Research Group, Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy

  5. 8

    McMaster University, Hamilton, Canada

  6. 9

    National Cancer Institute of Canada, Clinical Trials Group, Edith Eisenhauer Chair in Clinical Cancer Research, Queen's University, Kingston, Ontario, Canada

  7. 10

    Departments of Oncology and Medicine, Queen's University, Kingston, Ontario, Canada

  8. 11

    Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA

Author Information

  1. 1

    Cancer Care Ontario Hematology Disease Site Group, Toronto, Ontario, Canada

  2. 2

    Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada

  3. 3

    Division of Hematology/Oncology, Department of Medicine, University of Toronto Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Publication History

  1. Published Online: 4 FEB 2009
  2. Published Print: 27 JUN 2008

ISBN Information

Print ISBN: 9781405157476

Online ISBN: 9781444300857



  • Follicular lymphoma (FL) - second most common subtype of non-Hodgkin's lymphoma;
  • systematic reviews and meta-analyses;
  • limited stage follicular lymphoma and systemic therapy;
  • chemotherapy regimen;
  • role of interferon;
  • aggressive chemotherapy with ProMACE-MOPP and total nodal irradiation;
  • role of rituximab in FL;
  • rituximab as maintenance therapy for patients with indolent B-cell lymphomas;
  • radioimmunoconjugate therapy;
  • autologous stem cell transplantation (ASCT) following myeloablative therapy


This chapter contains sections titled:

  • Introduction

  • Literature-search strategy and inclusion

  • Search results

  • Systematic reviews and meta-analyses

  • Acknowledgment

  • References